bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 23, 2024
Abstract
Fibroblasts
are
critical
cells
that
shape
the
architecture
and
cellular
ecosystems
in
multiple
tissues.
Understanding
fibroblast
heterogeneity
their
spatial
context
health
disease
has
enormous
clinical
relevance.
In
this
study,
we
constructed
a
spatially-resolved
atlas
of
human
skin
fibroblasts
from
healthy
23
disorders.
We
define
6
major
populations
further
three
disease-specific
subtypes,
demonstrate
composition
different
types
disease.
characterise
human-specific
fibroblastic
reticular
cell
(FRC)-like
subtype
perivascular
niche
postulate
origin
prenatal
lymphoid
tissue
organiser
(LTo)-like
cells.
also
show
inflammatory
myofibroblasts
(
IL11
+
MMP1
CXCL5
IL7R+
)
conserved
disorders
cancers
across
provide
harmonised
nomenclature
for
integrates
previous
findings
other
Journal of Hematology & Oncology,
Год журнала:
2025,
Номер
18(1)
Опубликована: Март 28, 2025
Cancer-associated
fibroblasts
(CAFs)
are
key
players
in
cancer
development
and
therapy,
they
exhibit
multifaceted
roles
the
tumor
microenvironment
(TME).
From
their
diverse
cellular
origins,
CAFs
undergo
phenotypic
functional
transformation
upon
interacting
with
cells
presence
can
adversely
influence
treatment
outcomes
severity
of
cancer.
Emerging
evidence
from
single-cell
RNA
sequencing
(scRNA-seq)
studies
have
highlighted
heterogeneity
plasticity
CAFs,
subtypes
identifiable
through
distinct
gene
expression
profiles
properties.
multiple
mechanisms,
including
regulation
extracellular
matrix
(ECM)
remodeling,
direct
promotion
growth
provision
metabolic
support,
promoting
epithelial-mesenchymal
transition
(EMT)
to
enhance
invasiveness
growth,
as
well
stimulating
stem
cell
properties
within
tumor.
Moreover,
induce
an
immunosuppressive
TME
contribute
therapeutic
resistance.
In
this
review,
we
summarize
fundamental
knowledge
recent
advances
regarding
focusing
on
sophisticated
potential
targets.
We
discuss
various
strategies
target
ECM
modulation,
elimination,
interruption
CAF-TME
crosstalk,
CAF
normalization,
approaches
developing
more
effective
treatments.
An
improved
understanding
complex
interplay
between
is
crucial
for
new
targeted
therapies
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 12, 2025
Monoclonal
antibody
therapy
using
CD38
as
a
target
remains
central
to
managing
human
multiple
myeloma
(MM).
was
selected
early
on
for
mAb-mediated
MM,
driven
by
findings
from
an
Cluster
of
Differentiation
(CD)
Workshop.
The
first
CD38-targeting
be
approved
yielded
strong
trial
results,
significantly
improving
survival
rates
and
earning
widespread
patient
acceptance.
However,
resistance
the
later
emerged,
complicating
treatment
management.
Despite
CD38’s
still
role
in
MM
therapy,
too
little
attention
has
been
paid
its
broader
roles–not
only
marker
but
also
enzyme
adhesion
molecule
physiology.
This
review,
collaborative
effort
between
basic
scientists
clinical
experts,
explores
some
lesser-known
mechanisms
action
interactions
with
at
key
stages
treatment.
review
highlights
relevance
environment,
focusing
importance
bone
marrow
(BM)
niche.
goal
is
identify
new
agents
whose
unique
properties
may
enhance
tumor
eradication.
By
gaining
deeper
understanding
therapeutic
antibodies,
cells,
microenvironment
(TME),
it
hoped
that
previously
unrecognized
vulnerabilities
within
disease
revealed,
paving
way
more
effective
strategies.
Visualized Cancer Medicine,
Год журнала:
2025,
Номер
6, С. 4 - 4
Опубликована: Янв. 1, 2025
Cancer-associated
fibroblasts
(CAFs),
as
the
dominant
stromal
cell
population
in
tumor
microenvironment
(TME),
exhibit
substantial
heterogeneity,
with
subtypes
such
myofibroblastic
cancer-associated
(myCAFs)
and
inflammatory
(iCAFs)
playing
distinct
roles
cancer
progression.
MyCAFs,
defined
by
elevated
ACTA2
expression,
are
particularly
significant
promoting
growth,
remodeling
stroma,
contributing
to
an
immunosuppressive
TME.
Despite
advances
understanding
CAF
precise
role
of
myCAFs
invasion,
metastasis,
resistance
therapies,
especially
immunotherapy,
remains
underexplored.
This
perspective
highlights
recent
insights
into
myCAF
functions
within
TME,
emphasizing
their
potential
therapeutic
targets.
By
disrupting
formation
or
combining
myCAF-targeting
approaches
there
is
a
promise
for
improving
treatment
outcomes
overcoming
immunotherapy
cancer.
The EMBO Journal,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 11, 2025
Abstract
Fibroblasts
form
a
major
component
of
the
stroma
in
normal
mammary
tissue
and
breast
tumors.
Here,
we
have
applied
longitudinal
single-cell
transcriptome
profiling
>45,000
fibroblasts
mouse
gland
across
five
different
developmental
stages
during
oncogenesis.
In
gland,
diverse
stromal
populations
were
resolved,
including
lobular-like
fibroblasts,
committed
preadipocytes
adipogenesis-regulatory,
as
well
cycling
puberty
pregnancy.
These
specialized
cell
types
appear
to
emerge
from
CD34
high
mesenchymal
progenitor
cells,
accompanied
by
elevated
Hedgehog
signaling.
During
late
tumorigenesis,
heterogeneous
cancer-associated
(CAFs)
identified
models
cancer,
population
–
myofibroblastic
CAFs
(myCAFs)
that
transcriptionally
phenotypically
similar
senescent
CAFs.
Moreover,
Wnt9a
was
demonstrated
be
regulator
senescence
myCAFs.
findings
reflect
hierarchically
organized
compartment
provides
framework
better
understand
cancerous
states.
Cell Death and Differentiation,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 27, 2025
Abstract
Immunity
suffers
a
function
deficit
during
aging,
and
the
incidence
of
cancer
is
increased
in
elderly.
However,
most
models
employ
young
mice,
which
are
poorly
representative
adult
patients.
We
have
previously
reported
that
Triple-Therapy
(TT),
involving
antigen-presenting-cell
activation
by
vinorelbine
generation
TCF1
+
-stem-cell-like
T
cells
(scTs)
cyclophosphamide
significantly
improved
anti-PD-1
efficacy
anti-PD1-resistant
like
Triple-Negative
Breast
Cancer
(TNBC)
Non-Hodgkin’s
Lymphoma
(NHL),
due
to
T-cell-mediated
tumor
killing.
Here,
we
describe
effect
TT
on
TNBC
growth
tumor-microenvironment
(TME)
(6–8w,
human
puberty)
versus
(12
m,
40y-humans)
mice.
TT-efficacy
was
similar
adults,
as
CD8
scTs
were
only
marginally
reduced
adults.
single-cell
analyses
revealed
major
differences
TME:
adults
had
fewer
CD4
scTs,
B-naïve
NK-cells,
more
memory-B-cells.
Cancer-associated-fibroblasts
(CAF)
with
an
Extracellular
Matrix
(ECM)
deposition-signature
(Matrix-CAFs)
common
while
pro-inflammatory
stromal
populations
myofibroblasts
represented
Matrix-CAFs
mice
displayed
decreased
ECM-remodeling
abilities,
collagen
deposition,
different
pattern
interactions
other
TME.
Taken
together,
our
results
suggest
age-dependent
TME
should
be
considered
when
designing
preclinical
studies.
Journal of Gastroenterology and Hepatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 24, 2025
ABSTRACT
Background
and
Aim
Intrahepatic
cholangiocarcinoma
(ICC)
is
the
second
most
common
primary
liver
cancer
whose
incidence
increasing
globally.
However,
high
tumor
heterogeneity
of
ICC
restricts
efficacy
available
systematic
therapies.
We
aim
to
dissect
utilizing
high‐resolution
single‐cell
RNA
sequencing
identify
novel
therapeutic
targets.
Methods
performed
(scRNA‐seq)
26
samples
from
23
patients
spatial
transcriptomic
six
sections
patients.
Bulk
RNA‐seq
data
two
public
datasets
were
used
for
validation.
Additionally,
immunohistochemical
staining
multiplex
immunofluorescence
conducted
validate
infiltration
distribution
cells
in
microenvironment.
Results
discovered
that
malignant
exhibited
a
remarkably
degree
heterogeneity.
identified
basal‐like
cell
subpopulation
characterized
by
expression
basal
epithelial
related
genes
including
KRT5,
KRT6A,
KRT17.
The
was
activation
MET
signaling
extracellular
matrix
organization
associated
with
invasion
correlated
poor
prognosis.
Cell–cell
communication
analysis
further
showed
significant
HGF‐MET
interaction
between
inflammatory
cancer–associated
fibroblasts
(iCAFs)
cells.
found
iCAFs
major
source
HGF
environment
contributed
phenotype
formation
axis.
Conclusions
an
aggressive
subpopulation,
which
prognosis
ICC.
pathway
contributes
aggressiveness
serves
as
target
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 4, 2025
Abstract
Head
and
Neck
Squamous
Cell
Carcinomas
(HNSCC)
are
the
seventh
most
prevalent
form
of
cancer
associated
with
human
papilloma
virus
infection
(HPV-positive)
or
tobacco
alcohol
use
(HPV-negative).
HPV-negative
HNSCCs
have
a
high
recurrence
rate,
individual
patients’
responses
to
treatment
vary
greatly
due
level
cellular
heterogeneity
tumor
its
microenvironment.
Here,
we
describe
HNSCC
single
cell
atlas,
which
created
by
integrating
six
publicly
available
datasets
encompassing
over
230,000
cells
across
54
patients.
We
contextualized
relationships
between
existing
signatures
populations,
identified
new
subpopulations,
show
power
this
large-scale
resource
robustly
identify
associations
transcriptional
clinical
phenotypes
that
would
not
be
possible
discover
using
fewer
reveal
previously
undefined
myeloid
population,
sex-associated
changes
in
type
proportions,
novel
interactions
CXCL8-positive
fibroblasts
vascular
endothelial
cells.
Beyond
our
findings,
atlas
will
serve
as
public
for
high-resolution
characterization
HNSCC.